Oct 22 (Reuters) - Genscript Biotech Corp :
* GENSCRIPT BIOTECH ANNOUNCES COOPERATION ON BIOLOGIC LICENSE APPLICATION OF MRNA VACCINES AND ITS COMMERCIAL PRODUCTION
* UNIT ENTERS MASTER SERVICE AGREEMENT WITH SUZHOU ABOGEN BIOSCIENCE AND YUXI WALVAX BIOTECHNOLOGY FOR DEAL
* WALVAX TO BE APPLICANT FOR PROJECT, UNIT TO BE EXCLUSIVE SERVICES SUPPLIER FOR COMMERCIAL PRODUCTION OF PLASMID
* AS OF DATE, PHASE III CLINICAL TRIALS OF PROJECT APPROVED BY DRUG ADMINISTRATION AUTHORITIES OF MEXICO, INDONESIA & NEPAL
Further company coverage:
(Reuters.Briefs@thomsonreuters.com)
精彩评论